Hospitals buy some of their own medicines, and because they don't have large quantities, they sell them more expensively than pharmacies.
Early January 2013, the National Development and Reform Commission issued a notice deciding to adjust the maximum retail price limit for respiratory, antipyretic and specialty special drugs from February 1, 2013,*** involving 20 categories of drugs, more than 400 varieties, more than 700 representative dosage specifications, the average price reduction of 15%, of which the average reduction of high-priced drugs reached 20%.
According to Article 2 of the Drug Administration Law of the People's Republic of China, the definition of drugs: Drugs, as referred to in this Law, are substances used for the prevention, treatment and diagnosis of human diseases, the purposeful regulation of human physiological functions and the provision of indications or functional mainstays, usage and dosage, including traditional Chinese medicines, chemical medicines, and biologically based products, among others.
Expanded Information:
China's exports of APIs and active pharmaceutical ingredients are projected to grow to $9.9 billion in 2010 from $5.63 billion in 2007, while India's will grow to $2.76 billion in 2010 from $1.7 billion in 2007.
China's exports of these products mainly include antibiotics, vitamins, amino acids and organic acids, with major markets including the European Union, the United States, India and Japan. India will continue to lead in finished drug exports, which are expected to grow from $4.8 billion in 2007 to $6.4 billion in 2010, while China will grow from $700 million in 2007 to $1.88 billion in 2010.